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A novel synchrotron-based approach, known as microbeam radiation therapy
(MRT), currently shows considerable promise in increased tumour control and
reduced normal tissue damage compared with conventional radiotherapy.
Different microbeam widths and separations were investigated using a
controlled cell culture system and monoenergetic (5.35 keV) synchrotron
X-rays in order to gain further insight into the underlying cellular response to
MRT. DNA damage and repair was measured using ﬂuorescent antibodies
against phosphorylated histone H2AX, which also allowed us to verify the exact
location of the microbeam path. Beam dimensions that reproduced promising
MRT strategies were used to identify useful methods to study the underpinnings
of MRT. These studies include the investigation of different spatial conﬁgura-
tions on bystander effects.  H2AX foci number were robustly induced in
directly hit cells and considerable DNA double-strand break repair occurred by
12 h post-10 Gy irradiation; however, many cells had some  H2AX foci at the
12 h time point.  H2AX foci at later time points did not directly correspond
with the targeted regions suggesting cell movement or bystander effects as a
potential mechanism for MRT effectiveness. Partial irradiation of single nuclei
was also investigated and in most cases  H2AX foci were not observed outside
the ﬁeld of irradiation within 1 h after irradiation indicating very little chromatin
movement in this time frame. These studies contribute to the understanding
of the fundamental radiation biology relating to the MRTresponse, a potential
new therapy for cancer patients.
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1. Introduction
It is estimated that as many as 52% of all cancer patients
should receive radiotherapy (RT) (Delaney et al., 2005);
therefore, investigations into advances in this modality are
critical. Currently, conventional RT doses are limited by
adverse effects to normal tissues. Therefore, a primary goal in
radiation oncology is to ﬁnd a RT strategy that would increase
the therapeutic index (the ratio of curative effects to adverse
normal tissue effects).
1.1. MRT
One such advance is microbeam radiation therapy (MRT),
in which an array of high-dose planar X-ray microbeams (50–
250 keV) are delivered to a tumour site. Huge photon ﬂuxes
are required to deliver effective amounts of dose on a scale of
micrometres. Synchrotrons are capable of generating such
high-dose-rate X-ray microbeams with physical properties
that conventional sources do not possess. Investigations into
synchrotron MRT in animal models have indicated that
tumours can be ablated by MRTat radiation levels that spare
normal tissues (Dilmanian et al., 2002, 2003, 2005; Laissue et
al., 1998, 2007; Miura et al., 2006; Smilowitz et al., 2006;
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2008; Serduc et al., 2008; Crosbie et al., 2010). Therefore, the
therapeutic index for MRT has the promise of being greater
than conventional radiotherapy and may improve radiation-
based cancer treatment. The reason for this difference in
response is presently unknown but a possible mechanism is
inter-cellular effects between maximally and minimally irra-
diated cells. Indirect effects such as these are an important
phenomenon and a candidate for the beneﬁcial mechanism
responsible for the observed therapeutic index increase in
animal models following MRT (Crosbie et al., 2010).
1.2. Bystander effect
In the past, the paradigm was that only the directly irra-
diated cells were affected by the radiation, but in recent years
a paradigm shift has occurred that indicates cells outside the
effects of direct irradiation respond to the radiation, including
affecting the DNA (Nagasawa & Little, 1992; Littleﬁeld et al.,
1969; Prise & O’Sullivan, 2009; Yang et al., 2005; Han et al.,
2007; Seymour & Mothersill, 1997).
The bystander effect is a response that occurs in cells in
close proximity to cells that have been directly exposed to
radiation (Mothersill & Seymour, 1997; Seymour & Mother-
sill, 2006; Gerashchenko & Howell, 2003; Azzam et al., 1998).
Bystander effects have been shown to involve numerous
cellular changes including micronucleus formation (Belyakov
et al., 2001), cell death (Mothersill & Seymour, 1997; Lyng et
al., 2000), effects on clonogenicity (Mothersill & Seymour,
1997; Iyer et al., 2000), neoplastic transformation (Lewis et al.,
2001), increase in reactive oxygen species (Narayanan et al.,
1997; Azzam et al., 2002), induction of chromosome aberra-
tions (Littleﬁeld et al., 1969), sister chromosome exchanges,
mutations (Nagasawa & Little, 1992), genomic instability
(Kadhim et al., 1992), DNA double-strand breaks (Han et al.,
2007; Yang et al., 2005) and transcription alterations (Iyer et
al., 2000; Hickman et al., 1994). The bystander effect has been
shown to function through a number of mechanisms including
via soluble factors, such as chemokines and cytokines, which
can act over longer distances, or signalling via gap junctions,
which occurs between adjacent cells (Hei et al., 2008; Bentzen,
2006). In MRT, cells in the valley region between the
microbeam peaks may receive radiation doses of several Gray.
A bystander effect has been hypothesized to occur following
MRT (Dilmanian et al., 2005; Kashino et al., 2009). However,
we note a distinction between in vivo MRT (cell–cell
communication between maximally and minimally irradiated
cells) and the classical deﬁnition of the bystander effect, in
which neighbouring cells receive zero dose. Bystander effects
have been observed in human ﬁbroblasts when individual cell
nuclei were targeted using a monoenergenic X-ray microbeam
(Tomita et al., 2010).
1.3. DNA damage and repair
Ionizing radiation can cause DNA double-strand breaks, a
critical type of lesion for which the cell has a number of
mechanisms to deal with depending on lesion severity,
complexity and cell sensitivity. Typically a cell can repair the
double-strand break or undergo apoptosis. The number of
DNA double-strand breaks can be accurately estimated since
there is an almost one-to-one correlation to phosphorylation
of histone H2AX.  H2AX foci form relatively soon after
irradiation and the phosphorylation of H2AX spans a two
megabase region around a DNA double-strand break which is
observed as individual foci in the nucleus (Sedelnikova et al.,
2002).
Here, we investigate the effect of different spatial X-ray
microbeam conﬁgurations using DNA double-strand
breakage and repair as the endpoint. We found  H2AX foci
were robustly induced in directly targeted cells and, although
the presence of  H2AX foci was evident 12 h post-irradiation,
many cells still had residual foci. At the later time points these
foci did not directly correspond with the targeted regions.
Partial irradiation of single nuclei was also investigated and in
very few cases was a  H2AX focus observed within 1 h after
irradiation outside the precise ﬁeld of irradiation. These
experiments are important for gaining an understanding of the
cellular response to radiation damage which contributes to the
knowledge base in an effort to improve radiotherapy regimes
for cancer patients.
2. Methods
2.1. Cell lines
V79 Chinese hamster lung cells and NB1-RGB (human
ﬁbroblasts) cells were grown in DMEM, 10% FBS and anti-
biotics in a humidiﬁed 5% CO2 environment. Thirty minutes
prior to irradiation, 33258 Hoerchst dye was added to enable
visualization of chromatin for computer-assisted targeting.
V79 cells were provided by Dr Kasai-Eguchi (Kanai et al.,
1997). NB1-RGB was obtained from the RIKEN Bio-resource
Center Cell Bank (Tsukuba, Ibaraki, Japan).
2.2. Irradiation of cells
The cell irradiations were carried out on beamline BL27B at
the Photon Factory synchrotron (part of the KEK high-energy
accelerator research organization) in Tsukuba, Japan, using a
10 mm   10 mm monoenergetic (5.35 keV) X-ray beam. We
used specially designed cell dish jigs which allowed us to
transfer positioning coordinates from the beamline micro-
scope to an off-line confocal microscope. A more complete
description of the system is given elsewhere (Usami et al.,
2006; Maeda et al., 2008; Kobayashi et al., 2001). Cells grown
on Mylar membrane bottomed dishes were given 5 ml of fresh
media, and a water immersion lens ( 40) was used to identify
cellular targets. The exposure rate was approximately 30 R s
 1
which is calculated to be equivalent to a dose rate of
approximately 0.3 Gy s
 1. The dose rate was measured using
an AXUV-100 absolute XUV silicon photodiode (Interna-
tional Radiation Detectors, Torrance, CA, USA) (Maeda et
al., 2008). The conversion of 30 R s
 1 to approximately 0.3 Gy
s
 1 is derived from the relationship of exposure (R) to air
kerma (dose in air) (Gy) and described by Greening (1985),
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Joule
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
  2:58   10
 4 Coulomb
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; ð1Þ
where W is the conversion factor from exposure to dose and is
the energy required to create an ion pair in air (33.97 J C
 1),
and 1 R = 2.58   10
 4 Ck g
 1. Therefore,
Dair ðGyÞ¼0:00876
Gy
R

 ð RÞ; ð2Þ
which is approximated to
Dair ðGyÞ¼0:01
Gy
R

 ð RÞ: ð3Þ
Hence 30 R s
 1 ’ 0.3 Gy s
 1.
2.3. cH2AX immunofluorescence staining
After irradiation of regions with 2 Gy, 5 Gy or 10 Gy, the
slides were ﬁxed for 20 min with ice-cold 100% methanol and
then a quick exposure to ice-cold acetic acid. The Mylar dishes
were rinsed with three 5 min phosphate-buffered saline (PBS)
washes. Slides were treated three times for 10 min in a
blocking solution of 3% bovine serum albumin in PBS. Mouse
anti- H2AX antibody (Upstate, NY, USA) was added (1:500
in PBS) and incubated for 2 h in the dark at room tempera-
ture. The primary antibody was washed off with three PBS
washes, then the plates were exposed to a secondary goat anti-
mouse antibody (1:500 in PBS) conjugated with Alexa-488
(MolecularProbes, Oregon, USA) and incubated for 1 h in the
dark at room temperature. Slides were rinsed three times in
PBS and stained with 1 mgm l
 1 propidium iodide.  H2AX
images were acquired using an Olympus Fluoview confocal
system adapted to an Olympus BX51W1 ﬂuorescent micro-
scope with a 40  water immersion objective (Olympus,
Shinjuku-ku, Tokyo, Japan). Eight to ten Z sections with a
0.5 mm step size were de-convoluted to obtain  H2AX images.
3. Results
3.1. In vitro MRT configurations
We were able to test and clearly observe the exact targeting
of the microbeam using ﬂuorescently tagged  H2AX as a
marker with separations consistent with MRT conﬁgurations
previously used in animal studies. We selected a number of
different conﬁgurations, including 25 mm-wide beams with
centre-to-centre spacings of 50 mm, 75 mm, 100 mm, 175 mm,
200 mm and 300 mm; 50 mm-wide beams with centre-to-centre
spacings of 75 mm, 125 mm, 225 mm and 325 mm; 100 mm-wide
beams with centre-to-centre spacings of 200 mm; and 150 mm-
wide beams with centre-to-centre spacings of 200 mm (Fig. 1).
3.2. Late responses to in vitro MRT
We observed a large decrease in  H2AX staining intensity
in the regions directly irradiated with the microbeam by 12 h
post-irradiation. At this 12 h time point, individual foci within
the nucleus were evident but they were spread across the
region of MRT irradiation [Figs. 1(f)–1(j)]. The lower inten-
sity and dispersion of cells with foci made it difﬁcult to observe
the targeted patterning of X-rays as seen at the 1 h post-
irradiation time point. Similar results were observed in a
human ﬁbroblast cell line (NB1-RGB; Fig. 2).
3.3. Dose response of MRT
We performed MRTat 2 Gy, 5 Gy and 10 Gy using different
beam widths and beam spacings. We observed a linear
response with dose for ﬂuorescence indicative of increased
research papers
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Figure 1
DNA double-strand break repair in V79 cells after MRT pattern
emulation. Fluorescent staining with the  H2AX antibody (a marker of
DNA damage) shows synchrotron MRTemulation in cell culture using a
slit system of varying beam widths and interbeam spacings. The in-air
entrance dose was 10 Gy in all cases and the cells (V79 Chinese hamster
lung cells) were ﬁxed 1 h (a–e)and 12 h (f–j)post-irradiation. (a,f)2 5mm
beam width with centre-to-centre spacings of between 50 and 300 mm,
(b, g)5 0mm beam width with spacings of between 75 and 300 mm, (c, h)
100 mm beam width with a 200 mm centre-to-centre spacing, and (d, i)
150 mm beam width and a 200 mm spacing. (e, j) Zoomed images from
100 mm beam width with a 200 mm centre-to-centre spacing. Bars indicate
100 mm.DNA double-strand breaks at higher doses (Fig. 3). In a
separate experiment, to quantify the dose response signal, we
targeted individual nuclei with 0 Gy, 2 Gy, 5 Gy and 10 Gy and
determined the relative ﬂuorescence. A dose response was
observed (Fig. 3d).
3.4. Irradiation of part of the nucleus shows very little
chromatin movement at early time points
Only part of the nucleus was irradiated in cells at the edges
of microbeam-targeted areas. This was evident at the 1 h time
point but we were unable to draw this conclusion at the longer
time point because the signal had decreased and dispersed by
12 h. There were very few  H2AX foci beyond the apparent
radiation ﬁeld edge at 1 h post-irradiation; however, in some
cases  H2AX foci were observed near this area. These
observations were consistent for both cell lines tested (Fig. 4).
4. Discussion
The 5.35 keV X-ray microbeam facility at the Photon Factory
permits precise in vitro studies in sub-cellular radiobiology.
One has the ability to emulate planar MRTusing a slit system
to make arbitrary beam widths and spacings. We were able to
easily identify which cells had been irradiated by the
microbeam using the  H2AX immunohistochemical marker
of DNA damage.
We found the DNA damage response to this 5.35 keV
microbeam radiation increased from 2 Gy to 10 Gy (Fig. 3d).
A substantial amount of DNA repair had occurred over 12 h;
however, there were above-background foci present at this
time point. There are a number of possible reasons for these
foci being present. First, they could be residual difﬁcult-to-
repair DNA damage which are not yet repaired or have
retained the phosphorylation of H2AX histone. Alternatively,
they could be a secondary event caused by the bystander
effect which has been shown to have high levels near this time
point in some cell systems (Sedelnikova et al., 2007; Sokolov et
al., 2005). Another feature of the 12 h post-irradiated samples
was that the  H2AX foci were not limited to the region of
irradiation. This would be consistent with the bystander effect
but it is also possible that there was cell movement to these
locations within 12 h after irradiation. Both these possibilities
may contribute to the differential advantages observed
between tumour and normal tissue response to MRT when
compared with conventional radiotherapy.
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Figure 3
The DNA damage response of irradiated V79 cells. V79 cells were
exposed to 10 Gy (a), 5 Gy (b) and 2 Gy (c), using MRT patterned 5 keV
X-rays and stained for  H2AX 1 h after irradiation. The microbeam
widths were 100 mm with a centre-to-centre spacing of 200 mm. Individual
nucleus intensity was quantiﬁed by determining the relative ﬂuorescence
using a separate targeted single-cell irradiation (d). Intensities were
quantiﬁed using GeneTools (Syngene, Cambridge, UK). Error bars are
standard error of the mean of four cell nuclei for each dose. Bars indicate
100 mm.
Figure 2
Fluorescent staining with the  H2AX antibody shows synchrotron MRT
emulation in NB1-RGB human ﬁbroblast cultured cells. The geometry of
the microbeams was evident 1 h post-irradiation with (a)5 0mm beam
width and spacings of between 75 and 300 mm and (b) 150 mm beam width
with a 200 mm spacing. Most but not all of the DNA damage was repaired
by 12 h post-irradiation as shown in a representative area of the 12 h
50 mm beam sample (c). The in-air entrance dose was 10 Gy in all cases.
Bars indicate 100 mm.We also irradiated parts of the nucleus and in some cases
irradiated exactly half of the nucleus to try to understand
intra-nuclear responses to radiation. We observed a clear
demarcation where the radiation-induced DNA double-strand
breaks occurred as determined by  H2AX foci in half of the
nucleus (Fig. 4). After 1 h there appeared to be very little
movement of the chromatin; however, in a few cases it was
evident that foci had formed beyond the edge of the irradiated
area (Fig. 4; arrowheads). One explanation is that some
double-strand break regional movement (up to a few micro-
metres) occurred within the ﬁrst 30 s to 1 h. Similar effects
have been observed with  -particle irradiation (Aten et al.,
2004). Alternatively, there may have been some early signal-
ling of reactive oxygen species to cause DNA double-strand
breaks outside the region of the irradiation zone. This would
be consistent with previous reports of very little chromosome
movement at the site of double-strand breaks within the
nucleus after charged particles and ultrasoft X-rays (Jakob et
al., 2009; Nelms et al., 1998; Soutoglou et al., 2007; Splinter et
al., 2010; Tobias et al., 2010).
The single-slit microbeam system allows us to investigate
the effects of directly hit cells with less inﬂuence of
confounding factors such as valley doses between the beams,
although these factors may also play an important role in the
response of tissue to MRT.
It is important to note that the dose between the 5.35 keV
microbeams in this current study is virtually 0 Gy. The average
range of secondary electrons in water produced by a 5.35 keV
photon is very low, of the order of 1 mm based on stopping
power theory and the CSDA (continuous slowing down
approximation) theory. In contrast, the mean range of
secondary electrons from a 100 keV X-ray beam is approxi-
mately 70 mm, which accounts for the valley dose in
‘conventional’ MRT using poly-energetic X-rays with a mean
energy of about 100 keV. Photoelectric absorption is the
dominant interaction mechanism in the 5 keV energy range
and the probability of Compton scattering is low. For example,
the total mass energy absorption coefﬁcients ( en/ ) for water
at 5 keV and 100 keV are 4.129 m
2 kg
 1 and 0.017 m
2 kg
 1,
respectively (Khan, 2003). The total mass attenuation coefﬁ-
cient at 5 keV is dominated by the mass photoelectric
attenuation coefﬁcient ( / ). This means that the dose-
depositing electrons from the 5.35 keV X-ray beam deposit
their energy close to the site of the incident photon. In
addition, the effect of Fresnel diffraction by the slit edge
is so small that the shape (square) of the uncovered area
by the slit system is the same as the beam size at the sample
position.
Therefore, the valley dose between successive peaks is
essentially zero, using 5.35 keV X-rays. However, the valley
research papers
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Figure 4
Partial cell irradiation with a 25 mm-wide beam of (a–h) N1-RGB cells and (i–p) V79 cells reveals clear demarcation of radiation-induced DNA double-
strand breaks as determined by  H2AX foci. The in-air entrance dose was 10 Gy. Arrowheads point to  H2AX foci outside the apparent zone of
irradiation. The brightness and contrast settings for some images (c and l) have been adjusted to compensate for staining variation. Some cell images are
at a slightly higher zoom (l).dose is non-zero for poly-energetic MRT (50–250 keV) owing
to Compton scattering of secondary electrons and, depending
on the peak dose, may be several Gray. Nevertheless, we can
exploit a 0 Gy valley dose with 5.35 keV microbeams to tease
out radiobiological phenomena such as bystander effects,
cellular communication and cell migration.
In conclusion, these in vitro microbeam studies carried out
on the Photon Factory’s cellular radiobiology beamline may
contribute to our understanding of the mechanisms of in vivo
MRT which in turn could alter our understanding of funda-
mental radiation biology and therapy for cancer patients.
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